Access to COVID-19 Tools Accelerator

Research And Development Outsourcing Services Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, SAS, Microsoft, GlobalLogic, Organization, R, Health, HCL Technologies, Telecommunication, Softline, Aricent, Research, Acquisition, Fine chemical, Information technology, Creative industries, Access to COVID-19 Tools Accelerator, Accenture, Mindtree

The research and development outsourcing services market is expected to reach $11.10 billion in 2026 at a CAGR of 9.40%.

Key Points: 
  • The research and development outsourcing services market is expected to reach $11.10 billion in 2026 at a CAGR of 9.40%.
  • Therefore, increasing access to global outsourcing services will drive the research and development outsourcing services market.
  • The research and development outsourcing services market research report is one of a series of new reports that provides research and development outsourcing services market statistics, including research and development outsourcing services industry global market size, regional shares, competitors with a research and development outsourcing services market share, detailed research and development outsourcing services market segments, market trends and opportunities, and any further data you may need to thrive in the research and development outsourcing services industry.
  • This research and development outsourcing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

G20 ambitious on plan to roll out pandemic fund this year

Retrieved on: 
Friday, June 24, 2022
ACT, USD, Lists of countries and territories, Global, World Bank, Pandemic, COVID-19, GAVI, Bill & Melinda Gates Foundation, Union, Access to COVID-19 Tools Accelerator, Finance, The Global Fund to Fight AIDS, Tuberculosis and Malaria, PPR, World, Central bank, Therapy, FIF, Vaccine, CEPI, Research, Nature, Minister, G20, WHO, Animal, Health insurance

"I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."

Key Points: 
  • "I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."
  • G20 member states also highlighted that the fund would be inclusive in nature and allow access middle to low income countries to utilize it.
  • "This platform should be built on the experience of the ACT Accelerator, the Pandemic Influenza Framework and other mechanisms.
  • This is an important focus of the G20 health track under Minister Budi's leadership," he said.

G20 ambitious on plan to roll out pandemic fund this year

Retrieved on: 
Friday, June 24, 2022
ACT, USD, Lists of countries and territories, Global, World Bank, Pandemic, COVID-19, GAVI, Bill & Melinda Gates Foundation, Union, Access to COVID-19 Tools Accelerator, Finance, The Global Fund to Fight AIDS, Tuberculosis and Malaria, PPR, World, Central bank, Therapy, FIF, Vaccine, CEPI, Research, Nature, Minister, Multimedia, G20, WHO, Animal, Health insurance

"I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."

Key Points: 
  • "I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."
  • G20 member states also highlighted that the fund would be inclusive in nature and allow access middle to low income countries to utilize it.
  • Indonesian Health Minister Budi empasized that the G20 JFHTF has made progress in discussing further the idea of FIF establishment that was first introduced during 2021 Italian G20 presidency.
  • "This platform should be built on the experience of the ACT Accelerator, the Pandemic Influenza Framework and other mechanisms.

The Algorand Foundation Announces Staci Warden as New CEO

Retrieved on: 
Thursday, February 10, 2022
Harvard Institute for International Development, Access to COVID-19 Tools Accelerator, Growth, Multimedia, Parliamentary Information Technology Committee, STOA, Energy, Board, Association, United Nations Capital Development Fund, Leadership, Milken Institute, EMEA, Global South, Foundation, Positive economics, Non-fungible token, UNCDF, Trade Union Advisory Committee to the OECD, CEO, Adoption, Science, Center, Goal, European Parliament, Community governance, Bangladesh Technical Education Board, Nasdaq, Ecosystem, Department of the Treasury, Science and Technology Select Committee, JPMorgan Chase, Viridis, International development, Secretariat of the European Parliament, Management, Cryptocurrency, Stacy (given name), Decentralized finance

SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- The Algorand Foundation today announced the appointment of Staci Warden as its Chief Executive Officer.

Key Points: 
  • SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- The Algorand Foundation today announced the appointment of Staci Warden as its Chief Executive Officer.
  • Warden, who has served on the Algorand Foundation's Board since September 2021, steps into the additional role of CEO effective today.
  • Her appointment marks the next step in the Algorand Foundation's mission to catalyze the growth of the Algorand ecosystem.
  • The Foundation is committed to ensuring that the Algorand blockchain network is a key building block of this new, emergent digital-first economic model.

The Algorand Foundation Announces Staci Warden as New CEO

Retrieved on: 
Thursday, February 10, 2022
Harvard Institute for International Development, Access to COVID-19 Tools Accelerator, Growth, Parliamentary Information Technology Committee, STOA, Energy, Board, Association, United Nations Capital Development Fund, Leadership, Milken Institute, EMEA, Global South, Foundation, Positive economics, Non-fungible token, UNCDF, Trade Union Advisory Committee to the OECD, CEO, Adoption, Science, Center, Goal, European Parliament, Community governance, Bangladesh Technical Education Board, Nasdaq, Ecosystem, Department of the Treasury, Science and Technology Select Committee, JPMorgan Chase, Viridis, International development, Secretariat of the European Parliament, Management, Cryptocurrency, Stacy (given name), Decentralized finance

SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- The Algorand Foundation today announced the appointment of Staci Warden as its Chief Executive Officer.

Key Points: 
  • SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- The Algorand Foundation today announced the appointment of Staci Warden as its Chief Executive Officer.
  • Warden, who has served on the Algorand Foundation's Board since September 2021, steps into the additional role of CEO effective today.
  • Her appointment marks the next step in the Algorand Foundation's mission to catalyze the growth of the Algorand ecosystem.
  • The Foundation is committed to ensuring that the Algorand blockchain network is a key building block of this new, emergent digital-first economic model.

Bell Let's Talk and Brain Canada award more than $4M in mental health research funding for pioneering projects

Retrieved on: 
Tuesday, January 25, 2022
Theta, United States Public Health Service, Research, CAMH, Schizophrenia, Mental health, Gaps, LinkedIn, COVID-19, Addiction, Organization, Access, Bell Let's Talk, Talk, Dutch Association of Mental Health and Addiction Care, The Weather Network, Neuroscience, Health Canada, Centre for Addiction and Mental Health, Investor, University of Calgary, Access to COVID-19 Tools Accelerator, Solution, Randomness, Prefrontal, Indigenous peoples, Instagram, Health, Bell, Facebook, Artificial intelligence, Depression, Diagnosis, Quality of life, YouTube, Brain, TikTok, Treatment, Twitter, Government of Canada Building (North York), Hospital, Pinterest, Partnership, University, MONTRAL, Mobile phone, Medicine, Pharmaceutical industry, Medical device, Parenting

Brain Canada's contribution is made possible through the Canada Brain Research Fund, with financial support from Health Canada.

Key Points: 
  • Brain Canada's contribution is made possible through the Canada Brain Research Fund, with financial support from Health Canada.
  • The Bell Let's Talk-Brain Canada Mental Health Research Program recipient teams include some of the best researchers from across the country in the mental health field.
  • The Bell Let's Talk-Brain Canada Mental Health Research Program is supporting innovative projects that will meet the rising demand for improved, more accessible and more effective mental health care."
  • The Bell Let's Talk-Brain Canada Mental Health Research Program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and Brain Canada.

Vaccine Mandate Creates Best Opportunity for Small Manufacturers to Gain Workers

Retrieved on: 
Monday, November 15, 2021
Access to COVID-19 Tools Accelerator, Business valuation, Sale, Business, Thought, NOW, Employment, Antibody, Retirement, Pharmaceutical industry, Management

ASBURY, N.J., Nov. 15, 2021 /PRNewswire/ --Fran Brunelle, President of Accelerated Manufacturing Brokers, Inc. recently discussed how the vaccine mandate is creating the best opportunity in decades for small manufacturers to gain workers.

Key Points: 
  • ASBURY, N.J., Nov. 15, 2021 /PRNewswire/ --Fran Brunelle, President of Accelerated Manufacturing Brokers, Inc. recently discussed how the vaccine mandate is creating the best opportunity in decades for small manufacturers to gain workers.
  • The vaccine mandate creates a huge opportunity for small manufacturers to gain needed workers.
  • However, small manufacturers should be touting the benefits of working for a smaller firm to potential workers, including the following:
    In a smaller company, it's easier to interact with C-Suite executives and owners.
  • Employees often get to wear more hats in a small company, thus providing them with more valuable experience and cross-training.

AHF Salutes Biden Administration on Donation of 500M Doses of Pfizer’s Vaccine to Poor Nations

Retrieved on: 
Wednesday, June 9, 2021
White House, Federal Government, Public policy, Government, Medical Supplies, Health, Infectious diseases, General Health, Pharmaceutical, COVID-19, COVID-19 vaccines, Medicine, Articles, Clinical trials, Medical research, COVID-19 vaccine, Joe Biden, Vaccine, Access to COVID-19 Tools Accelerator, COVAX

After chiding the Biden Administration last week for announcing donation of 25 million COVD-19 vaccine doses (of a planned 80 million dose donation) to poor countries as too little, too late, AIDS Healthcare Foundation ( AHF ) today pivots to commend President Biden and his administration on its announcement of plans to purchase 500 million doses of Pfizers mRNA COVID-19 vaccine to donate and share with hard-hit, resource poor countries in an effort to derail the global pandemic.

Key Points: 
  • After chiding the Biden Administration last week for announcing donation of 25 million COVD-19 vaccine doses (of a planned 80 million dose donation) to poor countries as too little, too late, AIDS Healthcare Foundation ( AHF ) today pivots to commend President Biden and his administration on its announcement of plans to purchase 500 million doses of Pfizers mRNA COVID-19 vaccine to donate and share with hard-hit, resource poor countries in an effort to derail the global pandemic.
  • This latest US donation to the world is simply great news.
  • We salute President Biden and his administration for really stepping up this week on the global fight against COVID-19, particularly as G7 countries and representatives prepare to meet in Cornwall, United Kingdom, said Michael Weinstein, president of AHF.
  • Bidens move sets a high benchmark and serves as example to many G7 and other wealthy countries that have been hoarding their surplus vaccine doses.

Confidence in COVID-19 Vaccine in Older Adults Increasing, but Challenges in Registration and Access Continue

Retrieved on: 
Tuesday, March 9, 2021
Medicine, Medical specialties, COVID-19, COVID-19 vaccines, Vaccination, Vaccine, Virology, Medical research, Clinical trials, COVID-19 vaccine, Access to COVID-19 Tools Accelerator

However, only 22% believe they will have quick and easy access to a vaccine, emphasizing the need to reduce barriers to access to increase adoption among this population.

Key Points: 
  • However, only 22% believe they will have quick and easy access to a vaccine, emphasizing the need to reduce barriers to access to increase adoption among this population.
  • Round 1 coincided with Pfizer and Moderna both announcing the production of vaccines that are more than 90% effective at preventing COVID-19.
  • Round 2 closed just days ago now that more than 13% of the U.S. population, and nearly 50% of seniors, have received the vaccine.
  • Potential side effects continue to be the main reason influencing vaccine adoption or rejection,
    but significantly less than before.

SHAREHOLDER ALERT: WeissLaw LLP Reminds GIX, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations

Retrieved on: 
Friday, February 19, 2021
Companies, Articles, Medical research, COVID-19, World Health Organization, Economy, Reverse takeover, COVAX, AstraZeneca, Access to COVID-19 Tools Accelerator, American depositary receipt, Public company

GIX will combine with Uphealth and Cloudbreak via a reverse-merger to create a single publicly-traded digital healthcare company.

Key Points: 
  • GIX will combine with Uphealth and Cloudbreak via a reverse-merger to create a single publicly-traded digital healthcare company.
  • Under the terms of the agreement, ALXN shareholders will receive $60.00 and 2.1243 AstraZeneca American Depositary Shares ("ADS") (each ADS representing one-half of one ordinary share of AstraZeneca) for each share of ALXN they hold.
  • Under the terms of the merger agreement, STPK will acquire Stem through a reverse merger that will result in Stem becoming a publicly traded company.
  • Under the terms of the agreement, BRPA will acquire NeuroRx through a reverse merger, with NeuroRx surviving as the new publicly traded company.